Evaluation of delay discounting as a transdiagnostic research domain criteria indicator in 1388 general community adults

CONCLUSIONS: These results provide some support for DD as a transdiagnostic indicator, but also suggest that studies of individual syndromes may include confounding via comorbidities. Further systematic investigation of DD as an RDoC indicator is warranted.

via https://pubmed.ncbi.nlm.nih.gov/35080193/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20220216011003&v=2.17.5